1-7 of 7
Authors: David A. Cooper
Save search
Sort by
Journal Article

Improved adipose tissue function with initiation of protease inhibitor-only ART

PDF
Robert T. Maughan and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 11, November 2016, Pages 3212–3221, https://doi.org/10.1093/jac/dkw301
Published: 11 August 2016
Journal Article

Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults

PDF
Jasper van der Lugt and others
Journal of Antimicrobial Chemotherapy, Volume 62, Issue 4, October 2008, Page 852, https://doi.org/10.1093/jac/dkn342
Published: 15 August 2008
Journal Article

Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults Get access

PDF
Jasper van der Lugt and others
Journal of Antimicrobial Chemotherapy, Volume 61, Issue 5, May 2008, Pages 1145–1153, https://doi.org/10.1093/jac/dkn050
Published: 18 February 2008
Journal Article

The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity Get access

PDF
Mark A. Boyd and others
Journal of Antimicrobial Chemotherapy, Volume 57, Issue 6, June 2006, Pages 1161–1167, https://doi.org/10.1093/jac/dkl112
Published: 04 April 2006
Journal Article

Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients Get access

PDF
Reshma Saskia Autar and others
Journal of Antimicrobial Chemotherapy, Volume 56, Issue 5, November 2005, Pages 908–913, https://doi.org/10.1093/jac/dki354
Published: 04 October 2005
Journal Article

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy Get access

PDF
Alan Winston and others
Journal of Antimicrobial Chemotherapy, Volume 56, Issue 2, August 2005, Pages 380–387, https://doi.org/10.1093/jac/dki235
Published: 04 July 2005
Journal Article

Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy? Get access

PDF
Philippa J. Easterbrook and others
Journal of Antimicrobial Chemotherapy, Volume 43, Issue 3, March 1999, Pages 379–388, https://doi.org/10.1093/jac/43.3.379
Published: 01 March 1999